Found 5 matching trials
HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma
PHASE3This is a a multicenter, randomized, controlled, phase III trial comparing ...
Location
Beijing Cancer Hospital
The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery
PHASE3This is a phase III randomized, control, multi-center study of recombinant ...
Location
Beijing cancer hospital
The Study of JS001 Compared to High-Dose Interferon In Patients With Mucosal Melanoma That Has Been Removed by Surgery
PHASE2This is a phase II randomized, control, multi-center study of recombinant h...
Location
Beijing Cancer Hospital
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
PHASE3This randomized phase III trial is studying combination chemotherapy follow...
Location
Children's Hospital of Alabama
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
PHASE3This randomized phase III trial studies ipilimumab to see how well it works...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center